| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6R8T1UDM3V |
| InChI Key | HXYVTAGFYLMHSO-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H37NO2 |
| Molecular Weight | 299.5 |
| AlogP | 4.58 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 16.0 |
| Polar Surface Area | 49.33 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 21.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 5012 | - | - | 49-68 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Lipid-like ligand receptor (family A GPCR)
Cannabinoid receptor
|
- | - | - | - | 14-14 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Tourette Syndrome | 2 | D005879 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 71464 |
| ChEMBL | CHEMBL417675 |
| DrugBank | DB14043 |
| DrugCentral | 2045 |
| EPA CompTox | DTXSID4042254 |
| FDA SRS | 6R8T1UDM3V |
| Human Metabolome Database | HMDB0002100 |
| Guide to Pharmacology | 3622 |
| KEGG | C16512 |
| PubChem | 4671 |
| SureChEMBL | SCHEMBL19511663 |
| ZINC | ZINC000008035017 |